<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">PEN</journal-id>
<journal-id journal-id-type="hwp">sppen</journal-id>
<journal-id journal-id-type="nlm-ta">JPEN J Parenter Enteral Nutr</journal-id>
<journal-title>Journal of Parenteral and Enteral Nutrition</journal-title>
<issn pub-type="ppub">0148-6071</issn>
<issn pub-type="epub">1941-2444</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0148607112448674</article-id>
<article-id pub-id-type="publisher-id">10.1177_0148607112448674</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Letters to the Editor</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Hyperglycemia in the Newborn—Clinical Guidelines Are Needed but Must Be Based on Correct Reporting of the Data</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Beardsall</surname><given-names>Kathryn</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Costeloe</surname><given-names>Kate</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Dunger</surname><given-names>David B.</given-names></name>
</contrib>
</contrib-group>
<pub-date pub-type="epub-ppub">
<month>7</month>
<year>2012</year>
</pub-date>
<volume>36</volume>
<issue>4</issue>
<fpage>378</fpage>
<lpage>378</lpage>
<permissions>
<copyright-statement>© 2012 American Society for Parenteral and Enteral Nutrition</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">The American Society for Parenteral and Enteral Nutrition</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<p>The stated objective of the article by Arsenault et al,<sup><xref ref-type="bibr" rid="bibr1-0148607112448674">1</xref></sup> to develop guidelines for the management of glucose control in the neonate receiving parenteral nutrition, is an important one. The evidence base remains unclear, with wide variation in clinical practice, and many clinicians are keen for guidance. However, we are concerned that some of the evidence presented in this article is inaccurate and as such misleading.</p>
<p>First, the phrase “early continuous insulin infusion” is used to describe several studies that have important differences in methodology. The studies by Collins et al<sup><xref ref-type="bibr" rid="bibr2-0148607112448674">2</xref></sup> and Meetze et al<sup><xref ref-type="bibr" rid="bibr3-0148607112448674">3</xref></sup> treated babies once they had become hyperglycemic with insulin to reduce glucose levels and limit hyperglycemia, rather than reducing dextrose infusion rates. In comparison, the 2 studies by Beardsall et al<sup><xref ref-type="bibr" rid="bibr4-0148607112448674">4</xref>,<xref ref-type="bibr" rid="bibr5-0148607112448674">5</xref></sup> aimed to start insulin “early,” within 24 hours of birth (supported by 20% dextrose), to prevent hyperglycemia.</p>
<p>Second, the statement that the randomized controlled trial (NIRTURE, with the intervention of early insulin infusion) was “terminated early due to increased incidence of hypoglycemia and mortality” is incorrect. As is clearly stated in the original <italic>NEJM</italic> article, the study was stopped on the grounds of futility: “Although there was no statistical difference in the prespecified secondary outcome of ultrasound evidence of intracranial disease, the recommendation of the data and safety monitoring committee was based on a combination of futility associated with the primary outcome and concern about potential harm. After this suspension, the trial steering committee recommended that the trial be discontinued on the grounds of futility.”<sup><xref ref-type="bibr" rid="bibr5-0148607112448674">5</xref></sup></p>
<sig-block>
<sig>Kathryn Beardsall, MRCP, FRCPCH, MD<break/>
Kate Costeloe, FRCP, FRCPCH<break/>
David B. Dunger, FRCP, FRCPCH, MD<break/>
<italic>University of Cambridge, University Hospital NHS</italic><break/>
<italic>Foundation Trust, Cambridge, UK</italic></sig>
</sig-block>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="bibr1-0148607112448674">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Arsenault</surname><given-names>D</given-names></name>
<name><surname>Brenn</surname><given-names>M</given-names></name>
<name><surname>Kim</surname><given-names>S</given-names></name>
<etal/>
</person-group>. <article-title>A.S.P.E.N. clinical guidelines: hyperglycemia and hypoglycemia in the neonate receiving parenteral nutrition</article-title>. <source>JPEN J Parenter Enteral Nutr</source>. <year>2012</year>;<volume>36</volume>(<issue>1</issue>):<fpage>81</fpage>-<lpage>95</lpage>.</citation>
</ref>
<ref id="bibr2-0148607112448674">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Collins</surname><given-names>JW</given-names></name>
<name><surname>Hoppe</surname><given-names>M</given-names></name>
<name><surname>Brown</surname><given-names>K</given-names></name>
<name><surname>Edidin</surname><given-names>D</given-names></name>
<name><surname>Padbury</surname><given-names>J</given-names></name>
<name><surname>Ogata</surname><given-names>E</given-names></name>
</person-group>. <article-title>A controlled trial of insulin infusion and parentral nutrition in extremely low birth weight infants with glucose intolerance</article-title>. <source>J Pediatr</source>. <year>1991</year>;<volume>118</volume>:<fpage>921</fpage>-<lpage>927</lpage>.</citation>
</ref>
<ref id="bibr3-0148607112448674">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Meetze</surname><given-names>W</given-names></name>
<name><surname>Bowsher</surname><given-names>R</given-names></name>
<name><surname>Compton</surname><given-names>J</given-names></name>
<name><surname>Moorehead</surname><given-names>H</given-names></name>
</person-group>. <article-title>Hyperglycaemia in extremely-low birth weight infants</article-title>. <source>Biol Neon</source>. <year>1998</year>;<volume>74</volume>:<fpage>214</fpage>-<lpage>221</lpage>.</citation>
</ref>
<ref id="bibr4-0148607112448674">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Beardsall</surname><given-names>K</given-names></name>
<name><surname>Ogilvy-Stuart</surname><given-names>AL</given-names></name>
<etal/>
</person-group>. <article-title>Early elective insulin therapy can reduce hyperglycemia and increase insulin-like growth factor-I levels in very low birth weight infants</article-title>. <source>J Pediatr</source>. <year>2007</year>;<volume>151</volume>(<issue>6</issue>):<fpage>611</fpage>-<lpage>617</lpage>, <fpage>617 e1</fpage>.</citation>
</ref>
<ref id="bibr5-0148607112448674">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Beardsall</surname><given-names>K</given-names></name>
<name><surname>Vanhaesebrouck</surname><given-names>S</given-names></name>
<name><surname>Ogilvy-Stuart</surname><given-names>AL</given-names></name>
<etal/>
</person-group>. <article-title>Early insulin therapy in very-low-birth-weight infants</article-title>. <source>N Engl J Med</source>. <year>2008</year>;<volume>359</volume>(<issue>18</issue>):<fpage>1873</fpage>-<lpage>1884</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>